Overview

14th Annual Linda Morgante MS Nurse Leadership Program

Registration is closed for this activity.

Format

Live Virtual Meeting

Time to Complete

5.00 hr(s).

Date

Saturday, October 28, 2023 09:00 AM CDT

Expires On

October 28, 2023

The 14th Annual Linda Morgante MS Nurse Leadership Program will be held virtually on Saturday, October 28, 2023. This live virtual meeting will help multiple sclerosis (MS) nurses refine their ability to translate evidence-based guidelines and emerging clinical research into practice. Linda Morgante worked tirelessly as an MS nurse and touched the lives of thousands of physicians, nurses, as well as patients and their families. Linda inspired her students to strive for excellence in nursing and this program is named after her legacy. This program will feature didactic presentations, patient testimonials, as well as office hours for faculty to reinforce key points, engage in Q&A, and discuss current challenges and frame opportunities in professional development.

This activity is intended for nurses and advanced practice clinicians who manage patients with multiple sclerosis.

The treatment of MS has evolved such that there are now a multitude of approved disease-modifying therapies for clinicians and patients to choose from when managing the disease. However, selection of the optimal medication for an individual patient remains an issue given a lack of guidance, variations in practice/across practitioners, and disease heterogeneity. Additionally, despite the evolution of DMTs, medication compliance over the long-term remains challenging. Nurses are tasked with ensuring patient wellness despite these hurdles. Education of this target audience remains critical in the face of outcomes-driven patient care and with respect to diagnosis, adverse event and symptom management, and coordination of care. This live virtual program will allow MS nurses access to knowledge and strategies which they can take back to their practices, to implement in the service of comprehensive patient care and improved outcomes.

Upon completion of this activity, learners will be able to:
• Apply evidence-based diagnostic and assessment approaches for evaluating disease activity in the brain and spinal cord to develop individualized treatment plans in patients with MS

• Improve patient outcomes and adherence to therapy by identifying, assessing, and managing emerging MS-related symptoms and DMT-related adverse events.

• Employ treat-to-target strategies and precision medicine to improve patient long-term outcomes

10:00 AM*	Introduction & Welcome	Amy Perrin Ross and Colleen Harris
10:10 AM	Multiple Sclerosis Overview and Diagnosis	Aliza Ben-Zacharia
10:55 AM	Break
11:05 AM	Treatment Overview: Disease-Modifying Therapies and Relapse Management	Marie Namey
11:50 AM	Expert Discussion #1	Amy Perrin Ross, Colleen Harris, Aliza Ben-Zacharia and Marie Namey
12:10 PM	Evolution of Precision Medicine: Treat-to-Target Approaches	Lynn McEwan
12:30 PM	Office Hours and Case Presentation #1	Lynn McEwan
12:50 PM	Break
1:00 PM	Topics in MS Symptom Management	Tricia Pagnotta
2:00 PM	Office Hours and Case Presentation #2	Beverly Layton, Michelle Keating, Tricia Pagnotta, Amy Perrin Ross and Colleen Harris
2:25 PM	Lunch Break
2:40 PM	The Evolving Role of the MS Nurse: Multiple Sclerosis in the 21st Century	June Halper
2:55 PM	The Lived Experience of Multiple Sclerosis	Michelle Keating
3:20 PM	Expert Discussion #2	Amy Perrin Ross, Colleen Harris, and Michelle Keating
3:30 PM	Conclusion
3:35 PM	Adjournment
*Eastern Time Zone

Provided by the Academy for Continued Healthcare Learning (ACHL) and Annenberg Center for Health Sciences at Eisenhower.

Supported by educational grants from Bristol Myers Squibb, Novartis Pharmaceuticals Corporation, and EMD Serono.

Colleen Harris, MN, NP
Nurse Practitioner Manager
University of Calgary MS Clinic
Calgary, Alberta, Canada

Amy Perrin Ross, APN, MSN
Neuroscience Program Coordinator
Loyola University Chicago Medical Center
Maywood, Illinois

Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN
Assistant Professor
Hunter College NY and Mount Sinai School of Nursing
Nurse Practitioner
NP Adult Health Practice PC
New York, New York

June Halper, MSN, APN-C, MSCN, FAAN

Chief Executive Officer

Consortium of Multiple Sclerosis Centers

International Organization of Multiple Sclerosis Nurses

Hackensack, New Jersey

Michelle Keating, RN, MSCN

Nurse Consultant

President of MS Bright Spots of Hope

St. Louis, Missouri

Beverly Layton, RN, MSCN, BSN

MS Nurse Consultant

Birmingham, Alabama

Lynn McEwan, MScN

Nurse Practitioner

London Health Sciences Centre-University Hospital

London, Ontario Canada

Marie Namey APRN, MSCN-e

Independent MS Nurse Consultant

Cleveland, Ohio

Patricia Pagnotta, APRN

Nursing Clinical Preceptor

University of Central Florida

Neurology Associates and MS Center of Greater Orlando

Orlando, Florida

The Annenberg Center for Health Sciences at Eisenhower and the Academy for Continued Healthcare Learning (ACHL) require that the faculty participating in an accredited continuing education activity disclose all affiliations or other financial relationships within 24 months (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any ineligible companies. All relevant financial relationships have been mitigated prior to this activity.

Colleen Harris, MN, NP (Chair)

Consulting Agreements: Novartis; Sanofi Genzyme; EMD Serono

Amy Perrin Ross, APN, MSN (Chair)

Consulting Agreements: Alexion; Argenx; BMS; Cycle Pharma; EMD Serono; Genzyme; Horizon

Board Member: CMSC; IOMSN

Aliza Ben-Zacharia, PhD, DNP, ANP-BC, FAAN

Consulting Agreements: Biogen; EMD Serono

Beverly Layton, RN, BSN

Consulting Agreements: Sanofi Genzyme

Lynn McEwan, NP, MScN

Consulting Agreements: Roche; Sanofi Genzyme

The following faculty have no relevant financial relationships to disclose:

June Halper, MSN, APN-C, MSCN, FAAN

Michelle Keating, RN, MSCN

Marie Namey APRN, MSCN

Tricia Pagnotta, APRN

ACHL and Annenberg Center staff members and others involved with the planning, development, and review of the content for this activity have no relevant affiliations or financial relationships to disclose.

To receive credit, participants are required to complete the pretest, participate in the live virtual activity and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Katie Hacias at khacias@achlcme.org

In support of improving patient care, this activity has been planned and implemented by the Annenberg Center for Health Sciences at Eisenhower and the Academy for Continued Healthcare Learning. The Annenberg Center for Health Sciences at Eisenhower is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 5.00 ANCC contact hours and 1.50 pharmacology hours.

The content for this activity was developed independently of any ineligible company. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher or grantor(s).

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Clinicians should consult the current manufacturers’ prescribing information for these products. ACHL and The Annenberg Center for Health Sciences at Eisenhower requires the speaker to disclose that a product is not labeled for the use under discussion.

Katie Hacias
khacias@achlcme.org
Phone: (773)714-0705 ext. 159

Overview

14th Annual Linda Morgante MS Nurse Leadership Program

Program Description

Intended Audience

Activity Purpose

Learning Objectives

Meeting Schedule

Provider Information

Supporter Information

Faculty

Faculty Disclosure

Staff Disclosure

Method of Participation

Accreditation and Credit Designation

Disclaimer

Program Manager

Related Activities